Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Victoria Ingleson"'
Autor:
Ferdia A. Gallagher, Andrew N. Priest, Sarah J. Welsh, Athena Matakidou, Fulvio Zaccagna, Anne Y. Warren, Nicola Thompson, Victoria Ingleson, James N. Armitage, Timothy Eisen, Wendi Qian, Stephen Connolly, Kate Fife, Stephan Ursprung, Tristan Barrett, Jean Mullin, Antony C. P. Riddick, Grant D. Stewart, Andrea Machin
Publikováno v:
BJU internationalReferences. 130(2)
Objective: To explore translational biological and imaging biomarkers for sunitinib treatment before and after debulking nephrectomy in the NeoSun (European Union Drug Regulating Authorities Clinical Trials Database [EudraCT] number: 2005-004502-82)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25ac47905ee49b2540a3a7615bc9cd68
https://pubmed.ncbi.nlm.nih.gov/34549873
https://pubmed.ncbi.nlm.nih.gov/34549873
Autor:
Jean Mullin, Timothy Eisen, Victoria Ingleson, Sarah J. Welsh, Andrew N. Priest, Anne Y. Warren, Fulvio Zaccagna, Ferdia A. Gallagher, Andrea Machin, Pamela Whittaker, Kate Fife, Athena Matakidou, Antony C. P. Riddick, James N. Armitage, Katy Marie Dalchau, Tristan Barrett, Wendi Qian
Publikováno v:
Journal of Clinical Oncology. 35:e16087-e16087
e16087 Background: Sunitinib improves clinical outcomes in patients (pts) with mRCC. The single arm phase II NeoSun trial was designed to investigate its added value to nephrectomy, and to explore translational biological and imaging biomarkers. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8aff0623ad5fd7e051e2c84a55b2cd94
https://doi.org/10.1200/jco.2017.35.15_suppl.e16087
https://doi.org/10.1200/jco.2017.35.15_suppl.e16087